[go: up one dir, main page]

AP3342A - Imidazole derivatives as PDE10A enzyme inhibitors - Google Patents

Imidazole derivatives as PDE10A enzyme inhibitors

Info

Publication number
AP3342A
AP3342A AP2013006928A AP2013006928A AP3342A AP 3342 A AP3342 A AP 3342A AP 2013006928 A AP2013006928 A AP 2013006928A AP 2013006928 A AP2013006928 A AP 2013006928A AP 3342 A AP3342 A AP 3342A
Authority
AP
ARIPO
Prior art keywords
enzyme inhibitors
imidazole derivatives
pde10a enzyme
pde10a
imidazole
Prior art date
Application number
AP2013006928A
Other languages
English (en)
Other versions
AP2013006928A0 (en
Inventor
Jacob Nielsen
Jan Kehler
Mauro Marigo
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AP2013006928A0 publication Critical patent/AP2013006928A0/xx
Application granted granted Critical
Publication of AP3342A publication Critical patent/AP3342A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AP2013006928A 2010-11-19 2011-11-18 Imidazole derivatives as PDE10A enzyme inhibitors AP3342A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201001045 2010-11-19
PCT/DK2011/000136 WO2012065612A1 (fr) 2010-11-19 2011-11-18 Dérivé d'imidazole en tant qu'inhibiteurs de l'enzyme pde10a

Publications (2)

Publication Number Publication Date
AP2013006928A0 AP2013006928A0 (en) 2013-06-30
AP3342A true AP3342A (en) 2015-07-31

Family

ID=45217102

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2013006928A AP3342A (en) 2010-11-19 2011-11-18 Imidazole derivatives as PDE10A enzyme inhibitors

Country Status (32)

Country Link
EP (1) EP2640731B9 (fr)
JP (1) JP5937608B2 (fr)
KR (1) KR101916487B1 (fr)
CN (1) CN103328487B (fr)
AP (1) AP3342A (fr)
AR (1) AR083926A1 (fr)
AU (1) AU2011331607B2 (fr)
BR (1) BR112013012378A2 (fr)
CA (1) CA2817663C (fr)
CR (1) CR20130226A (fr)
DK (1) DK2640731T3 (fr)
EA (1) EA027082B1 (fr)
EC (1) ECSP13012698A (fr)
ES (1) ES2547090T3 (fr)
GE (1) GEP20156346B (fr)
GT (1) GT201300130A (fr)
HU (1) HUE025596T2 (fr)
JO (1) JO3089B1 (fr)
ME (1) ME02193B (fr)
MY (1) MY163327A (fr)
NZ (1) NZ610353A (fr)
PE (1) PE20141534A1 (fr)
PH (1) PH12013500968A1 (fr)
PL (1) PL2640731T3 (fr)
PT (1) PT2640731E (fr)
RS (1) RS54210B1 (fr)
SG (1) SG190282A1 (fr)
SI (1) SI2640731T1 (fr)
TW (1) TWI541245B (fr)
UA (1) UA112065C2 (fr)
WO (1) WO2012065612A1 (fr)
ZA (1) ZA201303607B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8552045B2 (en) 2010-11-19 2013-10-08 H. Lundbeck A/S Tricyclic imidazole compounds as PDE10 inhibitors
CN103619841B (zh) * 2011-01-11 2017-03-29 桑诺维恩药品公司 杂芳基化合物及其使用方法
WO2013045607A1 (fr) * 2011-09-30 2013-04-04 H. Lundbeck A/S Dérivés tricycliques hétéroaromatiques liés à de la quinazoline pouvant être utilisés en tant qu'inhibiteurs de l'enzyme pde10a
WO2013107856A1 (fr) * 2012-01-20 2013-07-25 H. Lundbeck A/S Dérivés d'imidazole utilisés comme inhibiteurs d'enzymes pde10a
EP2861596B1 (fr) * 2012-06-19 2019-03-20 Sunovion Pharmaceuticals Inc. Composés hétéroaryles et leurs procédés d'utilisation
CN103435617B (zh) * 2013-08-22 2016-04-27 南京华安药业有限公司 一种6,7-二氢-5H-吡咯并[1,2-a]咪唑-2-甲醛的合成方法
JO3627B1 (ar) 2015-04-30 2020-08-27 H Lundbeck As إيميدازو بيرازينونات على هيئة مثبطات pde1
TWI729109B (zh) 2016-04-12 2021-06-01 丹麥商Ｈ 朗德貝克公司 作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮
CN109843884B (zh) 2016-10-18 2022-03-04 H.隆德贝克有限公司 作为pde1抑制剂的咪唑并吡嗪酮、吡唑并嘧啶酮和吡唑并吡啶酮
MX2019004859A (es) 2016-10-28 2019-06-20 H Lundbeck As Tratamientos de combinacion que comprenden la administracion de imidazopirazinonas.
RS60716B1 (sr) 2016-10-28 2020-09-30 H Lundbeck As Kombinovane terapije koje obuhvataju imidazopirazinone za lečenje psihijatrijskih i/ili kognitivnih poremećaja
WO2020094591A1 (fr) 2018-11-06 2020-05-14 H. Lundbeck A/S Inhibiteurs de pde10a pour le traitement de symptômes négatifs et de troubles cognitifs chez un patient souffrant de schizophrénie
CN109776527A (zh) * 2019-02-21 2019-05-21 药雅科技(上海)有限公司 一种5-溴-7-氮杂吲哚的合成方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009152825A1 (fr) * 2008-06-20 2009-12-23 H. Lundbeck A/S Nouveau dérivés de phénylimidazole convenant comme inhibiteurs de l'enzyme pde10a

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307865D0 (en) 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
US5571775A (en) 1994-07-11 1996-11-05 Dowelanco N-aryl[1,2,4]triazolo[1,5-a]pyridine-2-sulfonamide herbicides
US20030032579A1 (en) 2001-04-20 2003-02-13 Pfizer Inc. Therapeutic use of selective PDE10 inhibitors
IL149106A0 (en) 2001-04-20 2002-11-10 Pfizer Prod Inc Therapeutic use of selective pde10 inhibitors
CN1809565A (zh) 2003-06-30 2006-07-26 奥坦纳医药公司 用于治疗癌症的吡咯并二氢异喹啉
US20070105840A1 (en) 2003-06-30 2007-05-10 Altana Pharma Ag Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors
WO2005012485A2 (fr) 2003-07-31 2005-02-10 Bayer Pharmaceuticals Corporation Procedes pour traiter le diabete, et les troubles associes, au moyen d'inhibiteurs des pde10a
JP2007523152A (ja) 2004-02-18 2007-08-16 ファイザー・プロダクツ・インク キナゾリンおよびイソキノリンのテトラヒドロイソキノリニル誘導体
JP2008501776A (ja) 2004-06-07 2008-01-24 ファイザー・プロダクツ・インク 肥満に関連し、かつメタボリックシンドロームに関連する状態の治療としてのホスホジエステラーゼ１０の阻害
US20060019975A1 (en) 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
US20060160814A1 (en) 2004-09-03 2006-07-20 Arrington Mark P Phosphodiesterase 10 inhibitors
UA102693C2 (ru) * 2008-06-20 2013-08-12 Х. Луннбек А/С Производные фенилимидазола как ингибиторы фермента pde10a
US8133897B2 (en) * 2008-06-20 2012-03-13 H. Lundbeck A/S Phenylimidazole derivatives as PDE10A enzyme inhibitors
TW201200516A (en) * 2009-12-17 2012-01-01 Lundbeck & Co As H Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors
TWI485151B (zh) * 2009-12-17 2015-05-21 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物
TWI481607B (zh) * 2009-12-17 2015-04-21 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑的２－芳基咪唑衍生物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009152825A1 (fr) * 2008-06-20 2009-12-23 H. Lundbeck A/S Nouveau dérivés de phénylimidazole convenant comme inhibiteurs de l'enzyme pde10a

Also Published As

Publication number Publication date
DK2640731T3 (en) 2015-08-31
EP2640731A1 (fr) 2013-09-25
EP2640731B1 (fr) 2015-07-08
BR112013012378A2 (pt) 2016-08-30
SI2640731T1 (sl) 2015-10-30
AP2013006928A0 (en) 2013-06-30
CR20130226A (es) 2013-09-03
ES2547090T3 (es) 2015-10-01
UA112065C2 (uk) 2016-07-25
AU2011331607B2 (en) 2016-05-19
GT201300130A (es) 2015-01-16
PH12013500968A1 (en) 2022-10-24
JO3089B1 (ar) 2017-03-15
ECSP13012698A (es) 2013-08-30
ME02193B (me) 2016-02-20
NZ610353A (en) 2015-01-30
GEP20156346B (en) 2015-08-10
PL2640731T3 (pl) 2015-11-30
ZA201303607B (en) 2014-07-30
WO2012065612A1 (fr) 2012-05-24
AR083926A1 (es) 2013-04-10
KR101916487B1 (ko) 2018-11-07
HUE025596T2 (en) 2016-03-29
MY163327A (en) 2017-09-15
CN103328487A (zh) 2013-09-25
JP5937608B2 (ja) 2016-06-22
TWI541245B (zh) 2016-07-11
EA201390741A1 (ru) 2013-11-29
PE20141534A1 (es) 2014-11-16
PT2640731E (pt) 2015-10-13
RS54210B1 (sr) 2015-12-31
KR20140009192A (ko) 2014-01-22
SG190282A1 (en) 2013-06-28
CA2817663A1 (fr) 2012-05-24
CA2817663C (fr) 2020-04-28
EA027082B1 (ru) 2017-06-30
EP2640731B9 (fr) 2015-11-25
CN103328487B (zh) 2015-11-25
JP2013542963A (ja) 2013-11-28
AU2011331607A1 (en) 2013-05-30
TW201300391A (zh) 2013-01-01

Similar Documents

Publication Publication Date Title
AP3342A (en) Imidazole derivatives as PDE10A enzyme inhibitors
IL209834A (en) Phenylimidazole derivatives as a10pde enzyme sequences
IL253102A0 (en) History of hydantoins used as kv3 inhibitors
IL221823A (en) Pipridine-4-Il-Aztidine Derivatives as Jack 1 Suppressors
ZA201204418B (en) 2-arylimidazole derivatives as pde10a enzyme inhibitors
GB201004179D0 (en) Enzyme inhibitors
ZA201204419B (en) Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors
GB201004178D0 (en) Enzyme inhibitors
ZA201204420B (en) Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors
IL216684A0 (en) Novel phenylimidazole derivative as pde10a enzyme inhibitor
PT2721009E (pt) Derivados de pirazole úteis como inibidores de aldosterona sintase
ZA201404533B (en) Quinoline derivatives as pde10a enzyme inhibitors
IL226344A0 (en) Imiazole derivatives as enzyme inhibitors@pde
GB201004309D0 (en) New enzyme inhibitors